within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BB07_Glipizide;
model Glipizide_1 
   extends Pharmacolibrary.Drugs.ATC.A.A10BB07_1;

  annotation(Documentation(
    info ="<html><body><p>Glipizide is an oral sulfonylurea antidiabetic drug used in the management of type 2 diabetes mellitus. It stimulates insulin secretion by the pancreas and is approved for use worldwide.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetic study in adult patients with type 2 diabetes, reported as a two-compartment model.</p><h4>References</h4><ol><li><p>Kosoglou, T, et al., &amp; Alton, KB (2005). Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. <i>Clinical pharmacokinetics</i> 44(5) 467–494. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544050-00002&quot;>10.2165/00003088-200544050-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15871634/&quot;>https://pubmed.ncbi.nlm.nih.gov/15871634</a></p></li><li><p>Wensing, G (1989). Glipizide: an oral hypoglycemic drug. <i>The American journal of the medical sciences</i> 298(1) 69–71. DOI:<a href=&quot;https://doi.org/10.1097/00000441-198907000-00012&quot;>10.1097/00000441-198907000-00012</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2665487/&quot;>https://pubmed.ncbi.nlm.nih.gov/2665487</a></p></li><li><p>Prendergast, BD (1984). Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents. <i>Clinical pharmacy</i> 3(5) 473–485. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6435940/&quot;>https://pubmed.ncbi.nlm.nih.gov/6435940</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Glipizide_1;
